Bio Inc. Redemption is a medical sim out now for mobile

By , on December 9, 2020
Last modified 2 months, 3 weeks ago

DryGin Studios has released Bio Inc. Redemption, the latest in its series of medical simulator games, on mobile for iOS and Android devices.

In Bio Inc. Redemption, you make decisions of life and death, where you can play around with different illnesses, interact with patients and either cure or torment them. The game is frighteningly realistic, featuring hundreds of diseases, virus, symptoms, diagnostic tests, treatments and other medical conditions.

The iOS and Android versions of Bio Inc. Redemption are ports of the earlier Steam version which released back in 2018. This one has a few extra features though, including two campaigns called Choose Life and Choose Death.

Choose Life puts your medical knowledge to the test as you try to save your patient’s life using the various different illnesses, medical tests and treatments in the game. Choose Death, on the other hand, has you using this knowledge against them, potentially bringing about the end of human civilisation as we know it. That sounds very 2020 to me.

Subscribe to AppSpy on

Outside of the campaign, you can also take part in a competitive tournament mode where players battle for the title of Doctor of Medicine alongside other rewards which will be spoon-fed to you slowly over the next month.

“Bio Inc.: Redemption offers players insight into the duality of medicine,” said J-F Mitchell from DryGin Studios. “Now, a new graduating class of med students on mobile devices can either choose to preserve and protect human life or use their knowledge to ruin it. Adding all of the new content specific for iOS and Android will give them plenty of moral choices to face!”
The game was announced to be coming to mobile only last month, and the Bio Inc. series itself has held more than 17 million players over the years.

Bio Inc. Redemption is now available to play from the iOS App Store or Google Play for Android. It’s a free to play title with in-app purchases.


Comments